| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
1994-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1997-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H09500358-A |
| titleOfInvention |
Therapeutic strategies for immunoinfectious cluster virus infection |
| abstract |
(57) [Summary]nOf immunocompetent cluster virus in humans characterized by the properties of autoantibodies produced by patients suffering from systemic rheumatoid ataxia and including the use of antibodies or fragments thereof that cross-react with epitopes on the immunoinfectious cluster virus. Therapeutic strategies for treatment. Additional therapeutic strategies include the use of U1 RNA or fragments thereof to treat the viral infection. |
| priorityDate |
1993-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |